Developing a Reliable Mouse Model for Cancer Therapy-Induced Cardiovascular Toxicity in Cancer Patients and Survivors

• Published in: Frontiers in cardiovascular medicine 2018-04, Vol.5, p.26
• Main Authors: Ko, Kyung Ae, Wang, Yin, Kotla, Sivareddy, Fujii, Yuka, Vu, Hang Thi, Venkatesulu, Bhanu P, Thomas, Tamlyn N, Medina, Jan L, Gi, Young Jin, Hada, Megumi, Grande-Allen, Jane, Patel, Zarana S, Milgrom, Sarah A, Krishnan, Sunil, Fujiwara, Keigi, Abe, Jun-Ichi
• Format: Article
• Language: English
• Subjects: atherosclerosis; Cancer treatment-related cardiovascular toxicity; Cardiovascular Medicine; disturbed blood flow; ionizing radiation; p90RSK
• ISSN: 2297-055X; 2297-055X
• DOI: 10.3389/fcvm.2018.00026

The high incidence of cardiovascular events in cancer survivors has long been noted, but the mechanistic insights of cardiovascular toxicity of cancer treatments, especially for vessel diseases, remain unclear. It is well known that atherosclerotic plaque formation begins in the area exposed to disturbed blood flow, but the relationship between cancer therapy and disturbed flow in regulating plaque formation has not been well studied. Therefore, we had two goals for this study; (1) Generate an affordable, reliable, and reproducible mouse model to recapitulate the cancer therapy-induced cardiovascular events in cancer survivors, and (2) Establish a mouse model to investigate the interplay between disturbed flow and various cancer therapies in the process of atherosclerotic plaque formation. We examined the effects of two cancer drugs and ionizing radiation (IR) on disturbed blood flow-induced plaque formation using a mouse carotid artery partial ligation (PCL) model of atherosclerosis. We found that doxorubicin and cisplatin, which are commonly used anti-cancer drugs, had no effect on plaque formation in partially ligated carotid arteries. Similarly, PCL-induced plaque formation was not affected in mice that received IR (2 Gy) and PCL surgery performed one week later. In contrast, when PCL surgery was performed 26 days after IR treatment, not only the atherosclerotic plaque formation but also the necrotic core formation was significantly enhanced. Lastly, we found a significant increase in p90RSK phosphorylation in the plaques from the IR-treated group compared to those from the non-IR treated group. Our results demonstrate that IR not only increases atherosclerotic events but also vulnerable plaque formation. These increases were a somewhat delayed effect of IR as they were observed in mice with PCL surgery performed 26 days, but not 10 days, after IR exposure. A proper animal model must be developed to study how to minimize the cardiovascular toxicity due to cancer treatment.